Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03201549 · ClinicalTrials.gov registry record · NA
The Effects of Increased Fructose Ingestion on FGF-21 Levels in Humans
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03201549 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT03201549, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary aim of this study is to examine the effect of fructose ingestion on serum FGF-21 levels in humans.
Interventions
- DIETARY_SUPPLEMENT oral fructose challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-07-30 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03201549
The ClinicalTrials.gov registry entry for NCT03201549 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oral fructose challenge is the first listed.
NCT03201549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03201549 about?
NCT03201549 is a clinical study titled "The Effects of Increased Fructose Ingestion on FGF-21 Levels in Humans". The primary aim of this study is to examine the effect of fructose ingestion on serum FGF-21 levels in humans.
What is the current status of trial NCT03201549?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-07-30. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT03201549?
The interventions under investigation include: oral fructose challenge (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03201549?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.